Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Artivion, Inc. Common Stock (NY:AORT)

46.67 +0.12 (+0.26%)
Streaming Delayed Price Updated: 3:35 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 Next >
News headline image
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Topics Retirement
News headline image
Artivion (AORT) Stock Is Up, What You Need To Know
Shares of medical device company Artivion (NYSE:AORT) jumped 4.6% in the afternoon session after analyst firm Canaccord Genuity reaffirmed its Buy rating and $51.00 price target, pointing to the... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Russell 2000 Stocks That Concern Us
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - cardiology,... 
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Oscar Health and Artivion Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
5 Must-Read Analyst Questions From Artivion’s Q3 Earnings Call
Artivion delivered a Q3 marked by strong revenue growth and a positive market response, as ongoing adoption of its stent grafts and On-X heart valves fueled performance. Management highlighted... 
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook
Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue... 
Via StockStory
News headline image
Artivion Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Artivion Inc (NYSE:AORT) Reports Q3 2025 Revenue Beat and Steady Earnings ↗
Artivion (AORT) Q3 2025 revenue beat expectations with 18.4% YoY growth, while EPS aligned with estimates. The medical device firm shows strong momentum. 
Via Chartmill
News headline image
Artivion’s (NYSE:AORT) Q3 Sales Top Estimates
Medical device company Artivion (NYSE:AORT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue guidance of $442... 
Via StockStory
News headline image
Artivion (AORT) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Artivion (NYSE:AORT) will be reporting earnings this Thursday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks We Find Risky
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Firing on All Cylinders: Artivion (NYSE:AORT) Q2 Earnings Lead the Way
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
News headline image
3 Reasons to Sell AORT and 1 Stock to Buy Instead
What a fantastic six months it’s been for Artivion. Shares of the company have skyrocketed 78.2%, hitting $41.02. This was partly thanks to its solid quarterly results, and the performance may have... 
Via StockStory
Topics Supply Chain
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
News headline image
Beyond The Numbers: 7 Analysts Discuss Artivion Stock ↗
Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinions spanning from bullish to bearish. 
Via Benzinga
News headline image
3 Russell 2000 Stocks with Warning Signs
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy Stocks
News headline image
3 Stocks Under $50 We’re Skeptical Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Topics Supply Chain
News headline image
1 Safe-and-Steady Stock to Consider Right Now and 2 We Ignore
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
PNC Financial Services Group, Truist Financial, U.S. Bancorp, Sweetgreen, and Artivion Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy World Trade
News headline image
3 Hyped Up Stocks with Questionable Fundamentals
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
Topics Supply Chain
News headline image
1 High-Flying Stock with Exciting Potential and 2 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
News headline image
1 Safe-and-Steady Stock to Target This Week and 2 We Find Risky
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
AORT Q2 Deep Dive: Product Momentum and Pipeline Advances Drive Upgraded Guidance
Medical device company Artivion (NYSE:AORT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.3% year on year to $113 million. The company’s full-year revenue guidance of $439... 
Via StockStory
News headline image
Deep Dive Into Artivion Stock: Analyst Perspectives (4 Ratings) ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.